UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant x Filed by a party other than the Registrant ¨
Check the appropriate box:
| ¨ | Preliminary Proxy Statement | |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ¨ | Definitive Proxy Statement | |
| x | Definitive Additional Materials | |
| ¨ | Soliciting Material Under §240.14a-12 | |
Portola Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| x | No fee required. | |||
| ¨ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
| (1) | Title of each class of securities to which transaction applies:
| |||
| (2) | Aggregate number of securities to which transaction applies:
| |||
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
| (4) | Proposed maximum aggregate value of transaction:
| |||
| (5) | Total fee paid:
| |||
| ¨ | Fee paid previously with preliminary materials. | |||
| ¨ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing: | |||
| (1) | Amount previously paid:
| |||
| (2) | Form, Schedule or Registration Statement No:
| |||
| (3) | Filing party:
| |||
| (4) | Date Filed:
| |||
EXPLANATORY NOTE
Portola Pharmaceuticals, Inc. (the “Company”) filed a copy of its Notice of Internet Availability of Proxy Materials (the “Notice”) on April 29, 2016. The Company is filing this updated copy of the Notice to provide the correct weekday of the Company’s 2016 Annual Meeting of Stockholders.
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders of
PORTOLA PHARMACEUTICALS, INC.
To Be Held On:
Friday, June 17, 2016 at 10:00 a.m. Pacific Time
at 270 East Grand Avenue, South San
Francisco, California 94080
COMPANY NUMBER
ACCOUNT NUMBER
CONTROL NUMBER
This communication presents only an overview of the more complete proxy
materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.
If you want to receive a paper or e-mail copy of the proxy materials you must request one. There is no charge to you for requesting a copy. To facilitate timely delivery, please
make the request as instructed below before June 7, 2016.
Please visit http://www.astproxyportal.com/ast/18320, where the following materials are available for
view:
TO OBTAIN
PROXY MATERIALS:
TO VOTE:
• Notice of Annual Meeting of Stockholders
• Proxy Statement
• Annual Report on Form 10-K
• Form of Electronic Proxy Card
TELEPHONE: 888-Proxy-NA (888-776-9962) or 718-921-8562
(for internal callers)
E-MAIL: info@amstock.com
WEBSITE:
http://www.amstock.com/proxyservices/requestmaterials.asp
ONLINE: To access your online proxy card, please visit www.voteproxy.com and follow the on-screen
instructions or scan the QR code with your smartphone. You may enter your voting instructions at www.voteproxy.com up until 11:59 PM Eastern Time the day before the cut-off or meeting date.
IN PERSON: You may vote your shares in person by attending the Annual Meeting.
TELEPHONE: To
vote by telephone, please visit www.voteproxy.com to view the materials and to obtain the toll free number to call. You may vote by telephone until 11:59 p.m Eastern Time the day before the meeting date.
MAIL: You may request a card by following the instructions above.
1. Election of Class III
directors to hold office until the 2019 Annual
Meeting of Stockholders:
Nominees:
Laura Brege
Hollings C. Renton
William Lis
2. Advisory vote on compensation of named executive officers.
3. To ratify the appointment of
Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016.
4. To transact such other
business as may properly come before the meeting or any adjournments or postponements thereof.
In their discretion, the proxies are authorized to vote upon such
other business as may properly come before the Annual Meeting. This proxy when properly executed will be voted as directed herein by the undersigned Stockholder. If no direction is made, this proxy will be voted “FOR ALL NOMINEES” in
Proposal 1, “FOR” Proposal 2, and “FOR” Proposal 3.
Please note that you cannot use this notice to vote by mail.